EMPOWER Study
Official Title
An observational, non-interventional, study of patients with Hereditary Angioedema in the United States and Canada (EMPOWER Study)
Study Details
The purpose of the study is to look at the effectiveness of lanadelumab in preventing HAE (Hereditary Angioedema) attacks . It will also examine the quality of life and the use of healthcare resources for HAE attacks before and after lanadelumab treatment.
Principal Investigator
Dr. H. James Wedner
IRB Number
201904067
Eligibility
1. Participants must have diagnosis of HAE Type I or Type II
2. Participants must have the ability to use a mobile device for data collection in the study
Volunteer Information
For more information about this study, contact Volunteer for Health at:
- 314.362.1000
- rprstaff@wustl.edu